Q32 Bio Inc.

QTTB

$12.80

-5.81%

2026-09-03 16:00:00 EDT-$0.79

Healthcare

Biotechnology

NASDAQ

Active Trading

Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Jodie Pope Morrison	Chief Executive Officer & Director	USD 1,002,798		1976	Active
Lee H. Kalowski	Chief Financial Officer & President	USD 792,770		1981	Active
Shelia Violette	Co-founder, Chief Scientific Officer & President of Research	USD 641,884	—	1961	Active
David Appugliese	Senior Vice President & Head of People	—		—	Active
Maria Marzilli	Chief Business Officer	—		—	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-04-30	2025	Jodie Morrison	Chief Chief Executive Officer and Director Director	Founder / CEO	$645.60K	$0	$335.28K	$220.79K	$355.08K	$2.12K	$1.56M
2026-04-30	2025	Lee Kalowski	Chief Chief Financial Officer and President President	C-Level	$565.00K	$0	$135.25K	$59.12K	$226.00K	$1.77K	$987.15K
2026-04-30	2025	Shelia Violette, Ph.D.	Chief Chief Scientific Officer	C-Level	$455.00K	$0	$95.25K	$37.31K	$182.00K	$4.88K	$774.45K
2026-04-30	2024	Jodie Morrison	Chief Chief Executive Officer and Director Director	Founder / CEO	$627.11K	$0	$0	$5.14M	$230.80K	$2.83K	$6.00M
2026-04-30	2024	Lee Kalowski	Chief Chief Financial Officer and President President	C-Level	$432.44K	$0	$0	$2.10M	$146.90K	$171.45K	$2.85M

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of QTTB

RELATIONS

Upstream

Undisclosed Biologics CDMO (Drug Substance - Monoclonal Antibody)Undisclosed CDMO (Drug Product - Fill/Finish)Undisclosed CRO (Clinical Trial Management)Undisclosed Raw Material / Consumables SuppliersHorizon Therapeutics (formerly, now Amgen)NASDAQ:AMGNUndisclosed Analytical/Testing Labs

Downstream

Akebia Therapeutics, Inc.NASDAQ:AKBA Amgen Inc. (formerly Horizon Therapeutics)NASDAQ:AMGNFuture Dermatology / Specialty Pharmacy Channel (Potential)

Proxies

Akebia Therapeutics Inc.NASDAQ:AKBA Amgen Inc.NASDAQ:AMGN MoonLake ImmunotherapeuticsNASDAQ:MLTXOppenheimer & Co. Inc.Unconfirmed

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer